| Basics |
|
Fulcrum Therapeutics, Inc.
|
| IPO Date: |
July 15, 2019 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$524.69M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.38 | 3.93%
|
| Avg Daily Range (30 D): |
$0.27 | 3.09%
|
| Avg Daily Range (90 D): |
$0.22 | 2.91%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.61M |
| Avg Daily Volume (30 D): |
.35M |
| Avg Daily Volume (90 D): |
.49M |
| Trade Size |
| Avg Trade Size (Sh.): |
104 |
| Avg Trade Size (Sh.) (30 D): |
60 |
| Avg Trade Size (Sh.) (90 D): |
73 |
| Institutional Trades |
| Total Inst.Trades: |
653 |
| Avg Inst. Trade: |
$1.55M |
| Avg Inst. Trade (30 D): |
$1.63M |
| Avg Inst. Trade (90 D): |
$1.5M |
| Avg Inst. Trade Volume: |
.18M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.62M |
| Avg Closing Trade (30 D): |
$2.71M |
| Avg Closing Trade (90 D): |
$1.78M |
| Avg Closing Volume: |
184.19K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-1.18
|
$-.28
|
$-.28
|
|
Diluted EPS
|
$-1.18
|
$-.28
|
$-.28
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -73.22M
|
$ -17.3M
|
$ -17.66M
|
|
Operating Income / Loss
|
$ -84.77M
|
$ -19.82M
|
$ -20.4M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -44.13M
|
$ -15.62M
|
$ M
|
|
PE Ratio
|
|
|
|
|
|
|
